Potential anxiolytic‐ and antidepressant‐like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist
- 1 April 2001
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 132 (7) , 1423-1430
Abstract
Several lines of evidence suggest a crucial involvement of glutamate in the mechanism of action of anxiolytic and/or antidepressant drugs. The involvement of group I mGlu receptors in anxiety and depression has also been proposed. Given the recent discovery of a selective and brain penetrable mGlu5 receptor antagonists, the effect of 2‐methyl‐6‐(phenylethynyl)‐pyridine (MPEP), i.e. the most potent compound described, was evaluated in established models of anxiety and depression. Experiments were performed on male Wistar rats or male Albino Swiss or C57BL/6J mice. The anxiolytic‐like effects of MPEP was tested in the conflict drinking test and the elevated plus‐maze test in rats as well as in the four‐plate test in mice. The antidepressant‐like effect was estimated using the tail suspension test in mice and the behavioural despair test in rats. MPEP (1 – 30 mg kg−1) induced anxiolytic‐like effects in the conflict drinking test and the elevated plus‐maze test in rats as well as in the four‐plate test in mice. MPEP had no effect on locomotor activity or motor coordination. MPEP (1 – 20 mg kg−1) did shorten the immobility time in a tail suspension test in mice, however it was inactive in the behavioural despair test in rats. These data suggest that selective mGlu5 receptor antagonists may play a role in the therapy of anxiety and/or depression, further studies are required to identify the sites and the mechanism of action of MPEP. British Journal of Pharmacology (2001) 132, 1423–1430; doi:10.1038/sj.bjp.0703923Keywords
This publication has 41 references indexed in Scilit:
- PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORSAnnual Review of Pharmacology and Toxicology, 1997
- Antidepressant-like Effects of a Partial Agonist at Strychnine-insensitive Glycine Receptors and a Competitive NMDA Receptor AntagonistNeuropharmacology, 1997
- The effects of repeated administration of diazepam, MK-801 and CGP 37849 on rat behavior in two models of anxietyEuropean Neuropsychopharmacology, 1996
- Adaptation of N-Methyl-D-Aspartate (NMDA) Receptors following Antidepressant Treatment: Implications for the Pharmacotherapy of DepressionPharmacopsychiatry, 1996
- Activation of group I mG1uRs potentiates NMDA responses in rat hippocampal slicesNeuroscience Letters, 1996
- The Excitatory Amino Acid Receptors: Their Classes, Pharmacology, and Distinct Properties in the Function of the Central Nervous SystemAnnual Review of Pharmacology and Toxicology, 1989
- Modulation of Glutamate Receptors: Molecular Mechanisms and Functional ImplicationsAnnual Review of Pharmacology and Toxicology, 1989
- Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the ratPharmacology Biochemistry and Behavior, 1986
- Précis ofThe neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal systemBehavioral and Brain Sciences, 1982
- Evaluation of a rapid technique for detecting minor tranquilizersNeuropharmacology, 1971